**Core Concept**
Thalassemia is a genetic disorder affecting hemoglobin production, leading to anemia. It results from mutations in the HBB (beta-globin) or HBA1/2 (alpha-globin) genes. These mutations disrupt the normal synthesis of the globin chains, crucial for hemoglobin function.

**Why the Correct Answer is Right**
The correct answer is a **deletion** or a **frame-shift mutation**, which typically leads to premature stop codons and truncation of the globin protein. This results in either a non-functional or a partially functional globin protein, causing a decrease in hemoglobin production and leading to thalassemia. The mutations often occur in the alpha-globin (HBA1/2) or beta-globin (HBB) genes.

**Why Each Wrong Option is Incorrect**
* **Option A:** Missense mutations result in a change in the amino acid sequence, but they usually do not lead to a complete loss of function, as seen in thalassemia.
* **Option B:** Splicing mutations affect the processing of RNA, but they primarily cause disorders like sickle cell anemia, not thalassemia.
* **Option C:** Transition mutations involve the substitution of one purine for another (A to G or G to A), which can lead to various genetic disorders but is not characteristic of thalassemia.
* **Option E:** Truncation mutations result in a premature stop codon, but they are more commonly associated with disorders like cystic fibrosis, not thalassemia.

**Clinical Pearl / High-Yield Fact**
Thalassemia major (also known as Cooley's anemia) is characterized by severe anemia, growth retardation, and skeletal deformities. The diagnosis is often made through hemoglobin electrophoresis, which can distinguish between different types of thalassemia.

**Correct Answer:** D. Frame-shift